Logo image of AVCN.CA

AVICANNA INC (AVCN.CA) Stock Price, Quote, News and Overview

TSX:AVCN - Toronto Stock Exchange - CA05368K1003 - Common Stock - Currency: CAD

0.27  +0.01 (+3.85%)

AVCN.CA Quote, Performance and Key Statistics

AVICANNA INC

TSX:AVCN (6/27/2025, 7:00:00 PM)

0.27

+0.01 (+3.85%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High0.55
52 Week Low0.21
Market Cap29.76M
Shares110.22M
Float80.35M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-12 2025-08-12
IPO07-18 2019-07-18


AVCN.CA short term performance overview.The bars show the price performance of AVCN.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10 -15

AVCN.CA long term performance overview.The bars show the price performance of AVCN.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 20 -20 -30

The current stock price of AVCN.CA is 0.27 CAD. In the past month the price increased by 1.89%. In the past year, price decreased by -32.5%.

AVICANNA INC / AVCN Daily stock chart

AVCN.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
BHC.CA BAUSCH HEALTH COS INC 1.71 3.26B
CRON.CA CRONOS GROUP INC 14.44 1.00B
DHT-UN.CA DRI HEALTHCARE TRUST 6.29 754.55M
GUD.CA KNIGHT THERAPEUTICS INC 52.27 572.87M
TLRY.CA TILRAY BRANDS INC N/A 553.79M
WEED.CA CANOPY GROWTH CORP N/A 355.12M
CPH.CA CIPHER PHARMACEUTICALS INC 26.06 327.17M
ACB.CA AURORA CANNABIS INC 9.68 313.25M
NGEN.CA NERVGEN PHARMA CORP N/A 256.72M
HITI.CA HIGH TIDE INC N/A 252.03M
OGI.CA ORGANIGRAM GLOBAL INC 30.67 246.34M
CRDL.CA CARDIOL THERAPEUTICS INC-A N/A 159.02M

About AVCN.CA

Company Profile

AVCN logo image Avicanna, Inc. is a medical cannabis company, which intends to engage in the business of discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-07-18. The firm's scientific platform commercializes over thirty products across various market segments: Medical Cannabis formulary (RHO Phyto), Medical cannabis care platform (MyMedi.ca), Pharmaceutical pipeline, and Active pharmaceutical ingredients (Aureus Santa Marta). RHO Phyto formulary offers a diverse range of proprietary products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca is a medical cannabis care platform and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. Aureus Santa Mart is a commercial-stage business providing a various forms CBD, THC and CBG to the Company's international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products.

Company Info

AVICANNA INC

480 University Avenue, Suite 1502

TORONTO ONTARIO M5G 1V2 CA

CEO: Aras Azadian

Employees: 38

AVCN Company Website

AVCN Investor Relations

Phone: 16472435283

AVICANNA INC / AVCN.CA FAQ

What is the stock price of AVICANNA INC today?

The current stock price of AVCN.CA is 0.27 CAD. The price increased by 3.85% in the last trading session.


What is the ticker symbol for AVICANNA INC stock?

The exchange symbol of AVICANNA INC is AVCN and it is listed on the Toronto Stock Exchange exchange.


On which exchange is AVCN.CA stock listed?

AVCN.CA stock is listed on the Toronto Stock Exchange exchange.


What is AVICANNA INC worth?

AVICANNA INC (AVCN.CA) has a market capitalization of 29.76M CAD. This makes AVCN.CA a Nano Cap stock.


How many employees does AVICANNA INC have?

AVICANNA INC (AVCN.CA) currently has 38 employees.


What are the support and resistance levels for AVICANNA INC (AVCN.CA) stock?

AVICANNA INC (AVCN.CA) has a support level at 0.26 and a resistance level at 0.29. Check the full technical report for a detailed analysis of AVCN.CA support and resistance levels.


Should I buy AVICANNA INC (AVCN.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AVICANNA INC (AVCN.CA) stock pay dividends?

AVCN.CA does not pay a dividend.


When does AVICANNA INC (AVCN.CA) report earnings?

AVICANNA INC (AVCN.CA) will report earnings on 2025-08-12.


What is the Price/Earnings (PE) ratio of AVICANNA INC (AVCN.CA)?

AVICANNA INC (AVCN.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).


AVCN.CA Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to AVCN.CA. When comparing the yearly performance of all stocks, AVCN.CA is a bad performer in the overall market: 89.31% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AVCN.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AVCN.CA. The financial health of AVCN.CA is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AVCN.CA Financial Highlights

Over the last trailing twelve months AVCN.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 67.99% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -12.17%
ROE -83.57%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%106.25%
Sales Q2Q%-1.88%
EPS 1Y (TTM)67.99%
Revenue 1Y (TTM)14.86%

AVCN.CA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 40% to AVCN.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.


Ownership
Inst OwnersN/A
Ins Owners16.39%
Short Float %N/A
Short RatioN/A
Analysts
Analysts40
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A